Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System

January 10, 2025
, 8:51 pm

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

Ouro Medicines’ drugs deplete disease-driving immune cells, allowing the immune system to reset with naïve cells that don’t attack the body. Monograph Capital founded the startup in partnership with GSK.

The post Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System appeared first on MedCity News.

Leave a Replay

HHS’ Proposed HIPAA Changes Are a Step in the Right Direction, But Some Providers May Struggle to Comply

When Algorithms Decide Who Lives and Who Suffers

Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare

Sign up for our Newsletter

HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.

Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System

Leave a Replay

Related Posts

HHS’ Proposed HIPAA Changes Are a Step in the Right Direction, But Some Providers May Struggle to Comply

When Algorithms Decide Who Lives and Who Suffers

Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare

Follow Us

Sign up for our Newsletter

Our Company

Resources

Connect

© All rights reserved

Contact Us